2-Chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)acetamide, 95%, 5g

(S)-1-(tert-Butoxycarbonyl)indoline-2-carboxylic acid, 97.0%, 5g

[3-(1H-tetrazol-5-yl)-4,5,6,7-tetrahydro-1-benzothien-2-yl]amine, 1g

Ethyl (2-amino-6-chloropyridin-3-yl)(methyl)carbamate, 98%, 1g

2-(methylamino)ethanesulfonic acid, 95.0%, 1g

4-Bromo-2-cyanobenzaldehyde, 95.0%, 250mg

Methyl 2-methyltetrahydrofuran-2-carboxylate, 95.0%, 1g

4-Fluoroindole-2-carboxylic acid, 95.0%, 5g

7-BROMO-1,5-NAPHTHYRIDIN-3-AMINE, 95.0%, 1g

Fmoc-L-Glutamic Acid-(OtBu) Monohydrate, 25g, >=99%, for Biochemistry, Glass Packaging

3-(4-Hydroxyphenyl)propionic Acid>98.0%(T)25g

(2S,4S)-1-(tert-Butoxycarbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 95.0%, 100mg

2,2,2-Trifluoro-3'-nitroacetophenone>98.0%(GC)5g